Zusammenfassung
Bei Erkrankungen, deren Manifestation eine große Varianz zeigen und die erhebliche Quoten an Spontanremissionen aufweisen, gestatten nur kontrollierte Studien des Verlaufes eine Aussage über ihre Beeinflußbarkeit durch die Thera-pie. Über die Ursache oder die Bedeutung bestimmter pathogenetischer Prozesse bei der Rückfallsneigung der Colitis ulcerosa und des Morbus Crohn im Kolon ist nichts Sicheres bekannt. Manche Patienten bleiben über Jahre von alien Symptomen frei, während andere wiederholt Rückfälle erleiden, obgleich sich beide Populationen bezüglich Alter, Geschlecht und Ausdehnung der Erkran-kung nicht voneinander unterscheiden. Besonders durch die Arbeiten von Sloan et al. (1950), EDWARDS und TRUELOVE (1963), GOLIGHER et al. (1968) und FAHRLÄNDER und SHALEV (1974) stehen Einblicke über den Verlauf der Colitis ulcerosa zur Verfügung.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ahren CL, Hulten LAG, Lindhagen J (1977) Pathological aspects in severe colitis. In: Gastrointestinal emergencies. Pergamon Press, Oxford
Banks BM, Korelitz BI, Zetzel L (1957) The course of non-specific ulcerative colitis. Gastroenterology 32:983–1013
Bargen J A, Jackman RJ, Kerr JG (1938) Studies of the life histories of patients with chronic ulcerative colitis (thromboulcerative colitis) with some suggestions for treatment. Ann Intern Med 12:339
Baron JH, Connell AM, Kanaghinis TG, Lennard-Jones JE, Jones FA (1962 a) Out-patient treatment of ulcerative colitis. Comparism between three doses of oral prednisone. Br Med J 1:441
Baron JH, Connell AM, Lennard-Jones JE, Jones FA (1962 b) Sulphasalazine and salicylazosulphadi- midine in ulcerative colitis. Lancet 1:1094
Bercovitz ZT (1953) A long-term evaluation of modern methods in the treatment of chronic ulcerative creitis. NY State J Med 53:2200
Bergman L, Krause U (1977) Crohn’s disease. Scand J Gastroenterol 12:937–944
Bockus HL, Roth JLA, Buchman E, Kaiser M, Staub WR, Finkelstein A, Valdes-Dapena A (1956) Life history of non-specific ulcerative colitis: relation to prognosis to anatomical and clinical varieties. Gastroenterologia (Basel) 86:549
Bonnevie D, Binder V, Anthonisen P, Riis P (1974) The prognosis of ulcerative colitis. Scand J Gastroenterol 9:81–91
Brooke BN (1956) Cortisone and ulcerative colitis: an adverse effect. Lancet II: 1175
Caprilli R, Vernia P, Torsoli A (1977) Fluid and acid-base imbalance. In: Gastrointestinal emergencies. Pergamon Press, Oxford
Carleson R, Fristedt B, Philipson J (1962) Ulcerative colitis. A follow-up investigation of a 20-year primary material. Acta Med Scand 172:647
Cullinan ER, McDougall IP (1957) The natural history of ulcerative colitis. Lancet 1:487–489
DeDombal FT, Geffen N, Darnborough A, Watkinson G, Goligher JC (1968) Radiological appearences of ulcerative colitis: an evaluation of their clinical significance. Gut 9:157
DeDombal FT, Burton IL, Clamp SE, Goligher JC (1974) Short-term course and prognosis of Crohn’s disease. Gut 15:435–443
Demling L, Hegemann G, Classen M, Emde J (1969) Die Prognose der Colitis ulcerosa. Dtsch Med Wochenschr 94:247–253
Demole MJ, Pollina Ph-J (1958) Le pronostic de la rectocolite ulcerohemorrogique en function de sousevolution arterienne. Praxis 47:943
Dennis C, Karlson KE (1961) Cancer risk in ulcerative colitis: formidability per patient year of late disease. Surgery 50:568
Dick HP, Grayson NI, Carpenter RG, Pelrie A (1964) Controlled trial of sulphasalazine in the treatment of ulcerative colitis. Gut 5:437–442
Edwards FC, Truelove SC (1963) The course and prognosis of ulcerative colitis. Gut 4:299–315
Evans JG (1971) Trends in mortality from ulcerative colitis in England and Wales. Gut 12:119–122
Fahrlander H (1966) Colitis ulcerosa. Dtsch Med Wochenschr 91:1953
Fahrlander H (1977) Klinik und Verlauf der ulcerosen Colitis. In: Kremer K, Kivelitz H (Hrsg) Colitis ulcerosa. Int. Symp. Diisseldorf, Juni 1976.
Thieme, Stuttgart, Fahrlander H, Shalev E (1974a) Colitis ulcerosa. Dtsch Med Wochenschr 99:2141–2147
Fahrlander H, Shalev E (1974 b) Die Enterocolitis regionalis Crohn. Dtsch Med Wochenschr 99:2207–2214
Farmer RG, Hawk WA, Turnbull RB (1975) Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology 68:627
Flood Ch, Cepor MS, Hiatt RB, Karush A (1956) Prognosis in chronic ulcerative colitis. J Chronic Dis 4:267
Gallagher ND, Goulston SJM, Wyndham N, Morrow W (1962) The management of fulminant ulcerative colitis. Gut 3:306–311
Goligher JC, DeDombal FT, Watts JM, Watkinson G (1968) Ulcerative colitis.
Bailliere, Tindall & Cassell, London, Goligher JC, Hoffman DC, DeDombal FT (1970) Surgical treatment of severe attacks of ulcerative colitis with special reference to the adventage of early operation. Br Med J 4:703
Jalan KN, Prescoff RI, Sircus W, Card WI, McManns JPA, Falconer CWA, Small WP, Smith AN, Bruce I (1970) An experience of ulcerative colitis. II. Short term outcome. Gastroenterology 59:589–597
Jarnum S, Jensen KB (1975) Fecal radioiodine excretion following intravenous injection of 131 J- albumin and 125-J-immunoglobuline G in chronic inflammatory disease. Gastroenterology 68:1433–1444
Kirsner JB, Woert M van (1964) Irreversibility and Reversibility in ulcerative colitis. Med Clin North Am 48:143–157
Kristensen E, Mosbech J (1977) Mortality from ulcerative colitis in Denmark 1960–1969. Scand J Gastroenterol 12:189–191
Law DH, Steinberg H, Sleisenger NH (1961) Ulcerative colitis with onset after the age of fifty. Gastroenterology 41:457
Lennard-Jones JE, Vivian AB (1960) Fulminating ulcerative colitis: recent experience in management. Br Med J 11:96
Lennard-Jones JE, Cooper EW, Newell AC, Wilson CWE, Jones FA (1962) Observations on idiopathic proctitis. Gut 3:201–206
Lennard-Jones JE, Misievicz J J, Parrish J A, Ritchie JK, Swarbrick ET, Williams ChB (1974) Prospective study of outpatients with extensive colitis. Lancet 1:1065–1067
Lennard-Jones JE, Ritchie JK, Hilder W, Spicer CC (1975) Assessment of severity in colitis: a preliminary study. Gut 16:579–584
Lennard-Jones JE, Ritchie JK, Zohrab WJ (1976) Proctocolitis and Crohn’s disease of the colon: a comparism of the clinical course. Gut 17:477–482
McDougall IPM (1964) The cancer risk in ulcerative colitis. Lancet 11:655
Mallett SJ, Lennard-Jones JE, Bingley J, Gilon E (1978) Colitis (Living with disease). Lancet 11:619–621
Mekhjian HS, Switz DM, Watts HD, Deren JJ, Katon RM, Beman FM (1979) National Cooperative Crohn’s Disease Study: Factors determining recurrence of Crohn’s disease after surgery. Gastroenterology 77:907
Mendeloff AI (1975) Crohn’s disease: What do recurrence rates mean? N Engl J Med 287:718–719
Misievicz II, Lennard-Jones JE, Connell AM, Baron JA, Jones FA (1965) Controlled trial of sulphasalazine in maintainance therapy for ulcerative colitis. Lancet 1:185–188
Morowitz DA, Kirsner JB (1969) Mortality in ulcerative colitis: 1930 to 1966. Gastroenterology 57:481
Miiller-Wieland K (1971) Ergebnisse einer mathematisch-statistischen Analyse des Merkmalver- bundes der Colitis ulcerosa zur Prognose. Verh Dtsch Ges Inn Med 77:537
Nefzger MD, Acheson ED (1963) Ulcerative colitis in the U.S. Army in 1944: Follow up with particular reference to mortality in cases and controls. Gut 4:183–191
Nugent FW, Veidenheimer MC, Zuberi S, Garabedian MM, Parikh NK (1970) Clinical course of ulcerative proctosigmoiditis. Am J Dig Dis 15:321–326
Prior P, Fielding JF, Waterhouse JA, Cooke WT (1970) Mortality in Crohn’s disease. Lancet 1:1135–1137
Pulvertaft CN (1964) The late results of gastric resection. Br J Surg 51:414
Ritchie JK, Powell-Tuck J, Lennard-Jones JE (1978) Clinical outcome of the first ten years of ulcerative colitis and proctitis. Lancet 1:1140–1143
Sloan WP, Bargen JA, Gage RG (1950) Life histories of patients with chronic ulcerative colitis: a review of 2000 cases. Gastroenterology 16:25–38
Storgaard L, Bischoff N, Henriksen FW, Fischerman K, Jarnum S (1979) Survival rate in Crohn’s disease and ulcerative colitis. Scand J Gastroenterol 14:225
Torsoli A (1977) Acute severe colitis. In: Gastrointestinal emergencies. Pergamon Press, Oxford, pp 59–61
Truelove SC, Jewell DP (1974) Intesive intraveneous regimen for severe attacks of ulcerative coli tis. Lancet 1:1067–1070
Truelove SC, Pena AS (1976) Course and prognosis of Crohn’s disease. Gut 17:192–201
Truelove SC, Witts CJ (1955) Cortisone in ulcerative colitis: final report on an therapeutical trial. Br Med J 11:1041–1048
Truelove SC, Watkinson G, Draper G (1962) Comparison of corticosteroides and sulphasalazine therapy in ulcerative colitis. Br Med J II: 1708
Truelove SC, Willoughby CP, Lee EG, Kettlewell MGW (1978) Further experience in the treatment of severe attacks of ulcerative colitis. Lancet II: 1086
Visick AH (1948) Measured radical gastrectomy: A review of 505 operations for peptic ulcer. Lancet 1:505 510
Wall AJ, Kirsner JB (1975) Ulcerative colitis and Crohn’s disease of the Colon: symptoms, signs and laboratory aspects. In: Kirsner JB, Shorter RG (eds) Inflammatory bowel disease. Lea & Febiger, Philadelphia
Wall AJ, Kirsner JB, Shorter RG (1975) Some observations on the course and prognosis of ulcerative colitis and Crohn’s disease. In: Kirsner JB, Shortner RG (eds) Inflammatory bowel disease. Lea & Febiger, Philadelphia
Watkinson G (1958) Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium. Br Med J 11:1077–1082
Watts JM, DeDombal FT, Goligher JC (1966) The long-term prognosis of ulcerative colitis. Br Med J 1:1447–1453
Watts JM, DeDombal FT, Goligher JC (1966) The early course of ulcerative colitis. Gut 7:16–31
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Müller-Wieland, K. (1982). Verlauf und Prognose. In: Bläker, F., et al. Dickdarm. Handbuch der inneren Medizin, vol 3 / 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67945-2_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-67945-2_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67946-9
Online ISBN: 978-3-642-67945-2
eBook Packages: Springer Book Archive